Trajectories of Anxiety and Depression in Cancer Patients, Risk and Predictive Factors and Supportive Care; Prognostic Awareness and Shared Decision Making.
NEOPSYCO STUDY: Trajectories of Anxiety and Depression in Cancer Patients, Risk and Predictive Factors and Supportive Care; Prognostic Awareness and Shared Decision Making.
Fundación Sociedad Española de Oncologia Médica
540 participants
Sep 12, 2024
OBSERVATIONAL
Conditions
Summary
To examine the trajectories of anxiety and depression symptoms over the course of oncological disease, and to assess potential predictors-sociodemographic (age, sex, marital status, employment status), clinical (tumor location, stage, treatment type, general health), psychological (coping strategies, quality of life, cognitive difficulties, fear of recurrence), and physical activity-and their association with support needs and utilization of psychosocial services.
Eligibility
Inclusion Criteria4
- Histologically confirmed diagnosis of solid cancer (non-hematologic) at any stage.
- Adult age (\>18 years).
- Candidate for perioperative systemic antineoplastic treatment or for advanced disease.
- Willingness to participate in the study and sign the informed consent form, as appropriate, before initiating any study-specific procedures, in accordance with good clinical practice requirements and local regulations.
Exclusion Criteria3
- Presence of a pre-existing psychiatric or neurodegenerative disorder that impairs the patient's ability to participate in the study.
- Presence of reading and writing difficulties that prevent the patient from completing the assessments.
- Receipt of oncological treatment in the past 2 years for another cancer.
Interventions
Participants complete standardized self-report questionnaires and undergo medical record review at three time points (baseline, 3 months, and 6 months) to assess psychological symptoms (anxiety, depression, somatization), coping strategies, quality of life, cognitive difficulties, physical activity, nutrition, supportive care needs, and informed decision-making in the context of cancer treatment. No experimental treatment or therapy is administered.
Locations(18)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07168096